DK2150253T3 - Anvendelse af 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridin-2-carboxamid til behandling af rygmarvsskader - Google Patents

Anvendelse af 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridin-2-carboxamid til behandling af rygmarvsskader

Info

Publication number: DK2150253T3
Authority: DK; Denmark
Prior art keywords: oxidopyridin; cyclopropylmethoxy; carboxamide; dichloro; pyridine
Prior art date: 2007-04-19

Application number

DK08787962.3T

Other languages

English (en)

Inventor

Philippe Delay-Goyet

Badia Ferzaz

Jocelyne Lolivier

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-19

Filing date

2008-04-16

Publication date

2011-07-25

2008-04-16 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2011-07-25 Application granted granted Critical

2011-07-25 Publication of DK2150253T3 publication Critical patent/DK2150253T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)

DK08787962.3T 2007-04-19 2008-04-16 Anvendelse af 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridin-2-carboxamid til behandling af rygmarvsskader DK2150253T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0702851A FR2915098B1 (fr)	2007-04-19	2007-04-19	Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
PCT/FR2008/000533 WO2008145840A2 (fr)	2007-04-19	2008-04-16	Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere

Publications (1)

Publication Number	Publication Date
DK2150253T3 true DK2150253T3 (da)	2011-07-25

Family

ID=38779706

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08787962.3T DK2150253T3 (da)	2007-04-19	2008-04-16	Anvendelse af 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridin-2-carboxamid til behandling af rygmarvsskader

Country Status (32)

Country	Link
US (1)	US8592443B2 (da)
EP (1)	EP2150253B1 (da)
JP (1)	JP5386477B2 (da)
KR (1)	KR101470043B1 (da)
CN (1)	CN101674829B (da)
AR (1)	AR066106A1 (da)
AT (1)	ATE503481T1 (da)
AU (1)	AU2008257321B2 (da)
BR (1)	BRPI0810446A2 (da)
CA (1)	CA2684172C (da)
CL (1)	CL2008001134A1 (da)
CY (1)	CY1111779T1 (da)
DE (1)	DE602008005873D1 (da)
DK (1)	DK2150253T3 (da)
EA (1)	EA015355B1 (da)
ES (1)	ES2363056T3 (da)
FR (1)	FR2915098B1 (da)
HR (1)	HRP20110459T1 (da)
IL (1)	IL201451A (da)
JO (1)	JO2662B1 (da)
MA (1)	MA31369B1 (da)
ME (1)	ME00934B (da)
MX (1)	MX2009011285A (da)
MY (1)	MY146657A (da)
NZ (1)	NZ580483A (da)
PA (1)	PA8776601A1 (da)
PL (1)	PL2150253T3 (da)
PT (1)	PT2150253E (da)
SI (1)	SI2150253T1 (da)
TW (1)	TWI411435B (da)
UY (1)	UY31033A1 (da)
WO (1)	WO2008145840A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2915099B1 (fr)	2007-04-19	2009-06-05	Sanofi Aventis Sa	Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
CA2892151A1 (en) *	2012-11-28	2014-06-05	Sanofi	Process for preparing 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide
WO2014083107A1 (en) *	2012-11-28	2014-06-05	Sanofi	METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF
WO2022159632A1 (en)	2021-01-20	2022-07-28	Alto Neuroscience, Inc.	Enhancement of camp signaling as a combination drug strategy for the treatment of depression and related conditions
WO2025079694A1 (ja) *	2023-10-12	2025-04-17	株式会社メドレックス	経皮吸収組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4193926A (en) *	1974-03-20	1980-03-18	Schering Aktiengesellschaft	4-(Polyalkoxy phenyl)-2-pyrrolidones
WO1995004045A1 (en) *	1993-07-28	1995-02-09	Rhone-Poulenc Rorer Limited	Compounds as pde iv and tnf inhibitors
GB9401460D0 (en)	1994-01-26	1994-03-23	Rhone Poulenc Rorer Ltd	Compositions of matter
GB9507297D0 (en)	1995-04-07	1995-05-31	Rh Ne Poulenc Rorer Limited	New composition of matter
US6196968B1 (en)	1997-06-02	2001-03-06	General Surgical Innovations, Inc.	Direct vision subcutaneous tissue retractor and method for use
US6177077B1 (en) *	1999-02-24	2001-01-23	Edward L. Tobinick	TNT inhibitors for the treatment of neurological disorders
JP2003519139A (ja) *	1999-12-23	2003-06-17	アイコスコーポレイション	環状ａｍｐ−特異的ホスホジエステラーゼ阻害剤
CA2439691A1 (en)	2001-03-02	2002-09-12	Bristol-Myers Squibb Company	Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
JP2005538972A (ja)	2002-07-02	2005-12-22	メルクフロストカナダアンドカンパニー	ジアリール置換エタンピリドンｐｄｅ４阻害剤
WO2004067006A1 (en)	2003-01-27	2004-08-12	Pharmacia Corporation	Combination of a pde iv inhibitor and a tnf-alpha antagonist
US7338950B2 (en) *	2003-10-07	2008-03-04	Renovis, Inc.	Amide compounds as ion channel ligands and uses thereof
JP2008543781A (ja) *	2005-06-10	2008-12-04	メモリー・ファーマシューティカルズ・コーポレイション	ホスフオジエステラーゼ４阻害剤
US20070021451A1 (en) *	2005-07-20	2007-01-25	Hamamatsu University School Of Medicine	Method for preventing or treating neurologic damage after spinal cord injury

2007
- 2007-04-19 FR FR0702851A patent/FR2915098B1/fr not_active Expired - Fee Related
2008
- 2008-04-15 PA PA20088776601A patent/PA8776601A1/es unknown
- 2008-04-16 NZ NZ580483A patent/NZ580483A/en not_active IP Right Cessation
- 2008-04-16 BR BRPI0810446-8A2A patent/BRPI0810446A2/pt not_active IP Right Cessation
- 2008-04-16 MY MYPI20094338A patent/MY146657A/en unknown
- 2008-04-16 EA EA200970969A patent/EA015355B1/ru not_active IP Right Cessation
- 2008-04-16 CN CN2008800125419A patent/CN101674829B/zh not_active Expired - Fee Related
- 2008-04-16 PT PT08787962T patent/PT2150253E/pt unknown
- 2008-04-16 WO PCT/FR2008/000533 patent/WO2008145840A2/fr not_active Ceased
- 2008-04-16 KR KR1020097021624A patent/KR101470043B1/ko not_active Expired - Fee Related
- 2008-04-16 ME MEP-2009-298A patent/ME00934B/me unknown
- 2008-04-16 MX MX2009011285A patent/MX2009011285A/es active IP Right Grant
- 2008-04-16 EP EP08787962A patent/EP2150253B1/fr active Active
- 2008-04-16 DK DK08787962.3T patent/DK2150253T3/da active
- 2008-04-16 DE DE602008005873T patent/DE602008005873D1/de active Active
- 2008-04-16 ES ES08787962T patent/ES2363056T3/es active Active
- 2008-04-16 AU AU2008257321A patent/AU2008257321B2/en not_active Ceased
- 2008-04-16 CA CA2684172A patent/CA2684172C/fr not_active Expired - Fee Related
- 2008-04-16 JP JP2010503548A patent/JP5386477B2/ja not_active Expired - Fee Related
- 2008-04-16 PL PL08787962T patent/PL2150253T3/pl unknown
- 2008-04-16 SI SI200830270T patent/SI2150253T1/sl unknown
- 2008-04-16 AT AT08787962T patent/ATE503481T1/de active
- 2008-04-16 HR HR20110459T patent/HRP20110459T1/hr unknown
- 2008-04-17 JO JO2008185A patent/JO2662B1/en active
- 2008-04-17 TW TW097114000A patent/TWI411435B/zh not_active IP Right Cessation
- 2008-04-18 UY UY31033A patent/UY31033A1/es not_active Application Discontinuation
- 2008-04-18 CL CL2008001134A patent/CL2008001134A1/es unknown
- 2008-04-18 AR ARP080101600A patent/AR066106A1/es unknown
2009
- 2009-10-05 US US12/573,316 patent/US8592443B2/en not_active Expired - Fee Related
- 2009-10-11 IL IL201451A patent/IL201451A/en not_active IP Right Cessation
- 2009-11-10 MA MA32335A patent/MA31369B1/fr unknown
2011
- 2011-06-28 CY CY20111100611T patent/CY1111779T1/el unknown

Also Published As

Publication number	Publication date
DE602008005873D1 (de)	2011-05-12
JP2010524905A (ja)	2010-07-22
JO2662B1 (en)	2012-06-17
WO2008145840A2 (fr)	2008-12-04
CY1111779T1 (el)	2015-10-07
AU2008257321A1 (en)	2008-12-04
CL2008001134A1 (es)	2009-01-16
UY31033A1 (es)	2008-11-28
KR101470043B1 (ko)	2014-12-05
IL201451A (en)	2013-04-30
WO2008145840A3 (fr)	2009-06-25
SI2150253T1 (sl)	2011-07-29
US20100137370A1 (en)	2010-06-03
ES2363056T3 (es)	2011-07-19
IL201451A0 (en)	2010-05-31
JP5386477B2 (ja)	2014-01-15
ATE503481T1 (de)	2011-04-15
EA015355B1 (ru)	2011-06-30
EP2150253A2 (fr)	2010-02-10
PT2150253E (pt)	2011-06-17
CA2684172A1 (fr)	2008-12-04
MA31369B1 (fr)	2010-05-03
PA8776601A1 (es)	2008-11-19
US8592443B2 (en)	2013-11-26
CN101674829A (zh)	2010-03-17
ME00934B (me)	2012-06-20
EP2150253B1 (fr)	2011-03-30
KR20090130063A (ko)	2009-12-17
EA200970969A1 (ru)	2010-02-26
PL2150253T3 (pl)	2011-08-31
AU2008257321B2 (en)	2013-08-15
BRPI0810446A2 (pt)	2014-10-14
FR2915098B1 (fr)	2009-06-05
FR2915098A1 (fr)	2008-10-24
MX2009011285A (es)	2009-11-02
NZ580483A (en)	2011-06-30
CN101674829B (zh)	2012-01-18
AR066106A1 (es)	2009-07-22
HRP20110459T1 (hr)	2011-07-31
CA2684172C (fr)	2015-10-27
MY146657A (en)	2012-09-14
TW200911248A (en)	2009-03-16
TWI411435B (zh)	2013-10-11
HK1142000A1 (en)	2010-11-26

Publication	Publication Date	Title
EP1854415A4 (en)	2015-01-21	SURGICAL TREATMENT DEVICE
DK1928438T3 (da)	2013-04-22	Anvendelse af ibudilast til behandling af stofafhængighed
SMP200900085B (it)	2010-11-12	3-imidazolil-indoli per il trattamento di malattieproliferative.
EP2124777A4 (en)	2013-06-05	DEVICES FOR SPINE COLUMN TREATMENT
DK3567035T3 (da)	2022-09-05	N-substituerede 2,5-dioxo-azolin-forbindelser til anvendelse ved behandling af cancer
PL3354276T3 (pl)	2020-09-21	Kompozycje do leczenia zapalenia przewodu pokarmowego
BRPI0916125A2 (pt)	2015-11-03	"dispositivo de tratamento"
EP2184024A4 (en)	2015-04-08	MEDICAL DEVICE
DK2117525T3 (da)	2014-02-03	Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte
IL206549A0 (en)	2011-07-31	Device for treating tinnitus & use thereof
BRPI0813670A2 (pt)	2014-12-30	Compostos para tratamento
DK2173831T3 (da)	2012-09-17	Brøndbehandling
DK3403657T3 (da)	2022-02-28	Anvendelse af oligouronater til behandling af slimhyperviskositet
BRPI0818170A2 (pt)	2017-05-16	5-cianotienopiridinas para o tratamento de tumores.
EP2116255A4 (en)	2011-05-04	MEANS FOR THE TREATMENT OF BACKBREAK INJURIES
ITMI20072397A1 (it)	2009-06-21	Apparecchiatura medicale per il trattamento extracorporeo
FR2919886B1 (fr)	2015-02-13	Appareil de verrouillage de portiere.
DK2150253T3 (da)	2011-07-25	Anvendelse af 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridin-2-carboxamid til behandling af rygmarvsskader
ZA201005306B (en)	2011-04-28	5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
DK4070800T3 (da)	2025-01-02	Cladribinkur til behandling af multipel sklerose
DE602006017692D1 (de)	2010-12-02	Wärmebehandlungsvorrichtung
FI20051207A0 (fi)	2005-11-25	Selän hoitolaite
DK2146714T3 (da)	2011-10-10	Anvendelse af 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridin-2-carboxamid til behandling af motoriske forstyrrelser i forbindelse med Parkinsons sygdom
BRPI0815055A2 (pt)	2017-05-23	aparelho de ciclone.
DK2001499T3 (da)	2013-09-08	Anvendelse af TGS-6 til behandling af osteoporose